Shenzhen - Delayed Quote • CNY
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
At close: April 26 at 3:04 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Xiaodong Gao | GM & Chairman of the Board | -- | -- | 1973 |
| Mr. Wang Jun | CFO & Deputy GM | -- | -- | 1977 |
| Ms. Yunxia Sun | Deputy GM & Non-Independent Director | -- | -- | 1981 |
| Mr. Zhihua Li | Deputy General Manager | -- | -- | 1974 |
| Ms. Qing Zhang | Deputy General Manager | -- | -- | 1974 |
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Zhengding High-tech Industrial Development Zone
No. 71, Menglong Street South District Zhengding Area
Shijiazhuang, 050800
China
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1,424
Description
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.
Corporate Governance
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jun 27, 2023Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available
Related Tickers
CNTA Centessa Pharmaceuticals plc
8.92
-0.11%
NMRA Neumora Therapeutics, Inc.
9.15
+0.99%
CGON CG Oncology, Inc.
41.00
+13.26%
UCB.BR UCB SA
124.55
+0.65%
GLYC GlycoMimetics, Inc.
1.6400
-4.09%
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
BLUE bluebird bio, Inc.
0.9228
+1.13%
IBRX ImmunityBio, Inc.
7.35
+43.84%